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Patched represses the Hedgehog signalling pathway by
promoting modification of the Smoothened protein
P.W. Ingham, S. Nystedt*, Y. Nakano, W. Brown, D. Stark, M. van den Heuvel†
and A.M. Taylor
Hedgehog (Hh) signalling plays a central role in many
developmental processes in both vertebrates and
invertebrates [1]. The multipass membrane-spanning
proteins Patched (Ptc) [2–4] and Smoothened (Smo)
[5–7] have been proposed to act as subunits of a
putative Hh receptor complex. According to this view,
Smo functions as the transducing subunit, the activity
of which is blocked by a direct interaction with the
ligand-binding subunit, Ptc [8]. Activation of the
intracellular signalling pathway occurs when Hh binds
to Ptc [8–11], an event assumed to release Smo from
Ptc-mediated inhibition. Evidence for a physical
interaction between Smo and Ptc is so far limited to
studies of the vertebrate versions of these proteins
when overexpressed in tissue culture systems [8,12]. To
test this model, we have overexpressed the Drosophila
Smo protein in vivo and found that increasing the levels
of Smo protein per se was not sufficient for activation
of the pathway. Immunohistochemical staining of wild-
type and transgenic embryos revealed distinct patterns
of Smo distribution, depending on which region of the
protein was detected by the antibody. Our findings
suggest that Smo is modified to yield a non-functional
form and this modification is promoted by Ptc in a non-
stoichiometric manner. 
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Results and discussion
Various lines of evidence indicate that Hh activates its
intracellular pathway by binding to Ptc [7–12], but the
precise manner in which Ptc regulates the pathway
remains unclear. Genetic studies have shown that Smo is
essential for Hh signalling and that, in the absence of Ptc,
Smo is constitutively active [5,6]. Murone et al. [8] have
shown that overexpression of vertebrate Smo in Hh-
responsive tissue culture cells is sufficient to activate tran-
scription of a Gli-dependent reporter gene, an effect that
can be abrogated by co-transfecting the cells with a Ptc
cDNA. Moreover, it was reported that Ptc and Smo could
be co-immunoprecipitated from such cells [8], suggesting
that Ptc suppresses Smo activity by a direct physical inter-
action. We have addressed this ‘sequestration’ model
in vivo by overexpressing smo in alternate segments of the
developing Drosophila embryo. Sequence encoding the
FLAG epitope tag was added near the 5′ end of the full-
length Drosophila smo cDNA, which was then cloned into
the UAS transformation vector pUAST [13]. Transgenic
flies carrying this construct were crossed to flies homo-
zygous for h–Gal4, which in the embryo drives expression
of the GAL4 transactivator in alternating segment-wide
Figure 1
(a) Stage 10 h–Gal4;UAS–lacZ embryo stained with monoclonal
anti-β-galactosidase antibody to reveal the expression of GAL4 driven
by the hairy gene control elements. Note the seven (1–7) principal
expression domains; expression in domains 2–4 was consistently
weaker than in the other domains. (b) Stage 11 h–Gal4;UAS–smo
embryo stained with monoclonal antibody 4D4 to reveal the pattern
of Wg protein expression. This was identical to that of wild-type
embryos, showing no evidence of the expansion of domains caused
by ectopic activation of the Hh pathway. (c) Cuticular preparation of
a smo3 homozygote, showing the typical zygotic null phenotype.
Note the continuous ‘lawn’ of denticles covering most of the ventral
surface. (d) Cuticular preparation of a smo3 homozygote expressing
the Flag–smo transgene under h–Gal4 control. Note the restoration
of naked cuticle in alternate segments (indicated in the abdominal
region by dots), corresponding to the regions in which the transgene
was expressed.
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domains under the control of regulatory elements of the
pair-rule gene hairy (h) [13] (see Figures 1a and 2i).
Transcription of the wingless (wg) gene, a principal target
of Hh signalling in the embryo, is restricted to cells imme-
diately adjacent to those expressing Hh (see Figure 2i).
Elimination of Ptc activity or ectopic expression of Hh
results in the expansion of each wg domain, such that they
come to occupy approximately half of every segment
[14,15]. We therefore analysed wg expression in the
h–Gal4;UAS–smo embryos to determine whether wg
expression is ectopically activated in alternate segments in
response to the overexpression of Smo. Contrary to expec-
tation, we found no evidence of ectopic activation of wg,
the embryos displaying an essentially wild-type pattern of
expression (Figure 1b). Moreover, such h–Gal4;UAS–smo
animals completed embryogenesis and developed into
viable adults (data not shown). A trivial explanation of the
failure of the overexpressed cDNA to activate the Hh
pathway could be that the activity of the encoded protein
has been compromised in some way, for instance, by addi-
tion of the epitope tag. To exclude this possibility, we
tested its ability to rescue smo loss-of-function mutations.
Expression of the tagged cDNA under the control of the
ubiquitous arm–Gal4 driver [16] rescued fully the cuticle
phenotype of homozygous null smo embryos (data not
shown). Expression of the same transgene under the
control of h–Gal4 in a smo null background rescued the
cuticular phenotype in alternate segments (Figure 1c,d).
To analyse the expression of the endogenous Smo protein,
we raised an antibody against the membrane-proximal
portion of the putative intracellular carboxy-terminal tail
of Smo (anti-SmoC antibody; see Figure 3d) and used this
to stain wild-type and transgenic embryos. In contrast to
the ubiquitous distribution of the smo mRNA (Figure 2a),
immunohistochemical staining of wild-type embryos with
the anti-SmoC antibody revealed a modulated distribution
of the protein (Figure 2b). Smo accumulates in a series of
sequentially repeating stripes, each of which is about one-
half a segment in width and spans the parasegmental
boundary, the site of Hh activity (see Figure 2i). Staining
of h–Gal4;UAS–smo embryos with the anti-SmoC antibody
revealed a significant increase in the levels of Smo protein
in the GAL4-expressing segments (Figure 2c); strikingly,
however, this staining was also restricted to cells flanking
the parasegmental boundary. To determine the precise
location of these Smo-positive cells, we probed embryos



















(a) Wild-type stage 11 embryo hybridised with a full-length smo
antisense probe, revealing the uniform distribution of smo mRNA.
(b) Stage 10 wild-type embryo probed with the rabbit anti-SmoC
antibody. Note the segmentally reiterated pattern of staining, the
antibody-positive cells spanning each parasegmental groove.
(c) Stage 10 h–Gal4;UAS–Flag–smo embryo probed with the rabbit
anti-SmoC antibody. Note the elevated levels of staining in six stripes
in alternating segments in the thoracic and abdominal region (dots)
corresponding to parts of hairy stripes 2–7 (see Figure 1a), and the
two additional domains of elevated expression in the cephalic region
(asterisks), which fall within hairy domain 1 (see Figure 1a).
(d) h–Gal4;UAS–Flag–smo embryo at a slightly later stage to that
shown in (c), stained with rabbit anti-SmoC antibody (blue) and anti-En
monoclonal antibody 4D9 (brown). Each stripe of Smo staining was
centred over an En stripe. In the cephalic region, the two strong stripes
of Smo expression within hairy domain 1 (asterisks) both coincided
with an En stripe. (e) Stage 10 embryo homozygous for the ptc null
allele ptcG12, stained with rabbit anti-SmoC antibody. Note the uniform
staining. (f) Stage 10 Kr–Gal4;UAS–hh embryo stained with rabbit
anti-SmoC antibody. Note the uniform staining between parasegments
5–9 (indicated by dots). (g) Stage 10 h–Gal4;UAS–Flag–smo embryo
stained with rabbit anti-SmoC antibody (blue) and anti-Wg monoclonal
antibody 4D4 (brown). Each stripe of Smo staining overlapped a Wg
stripe at its anterior margin. (h) Detail of embryo shown in (d).
(i) Schematic representation of gene expression domains in the
ectoderm of a stage 10 embryo. Two parasegmental boundaries are
shown, defined by the interface between cells expressing Wg and Ptc
(green) and those expressing En and Hh (orange). Note that Hh
secreted by the En-expressing cells signals in both directions,
stimulating transcription of wg and ptc in more anterior cells and ptc
(deep yellow) in more posterior cells; ptc is also expressed at lower
levels in all other non-En-expressing cells (pale yellow). As Ptc is
inactivated by Hh, these cells represent the domain of Ptc activity
(pale yellow bar). Blue bars, domains in which Smo is potentially
activated in response to Hh signalling and in which Smo protein was
detected using the rabbit anti-SmoC antibody; magenta bar, a domain
of hairy expression.
simultaneously with the anti-SmoC antibody and mono-
clonal antibodies for Engrailed (En) [17], a marker of Hh-
expressing cells [18], and Wg [19], a marker of
Hh-responding cells [14]. Double staining with the anti-
En antibody revealed that Smo accumulates in and around
cells expressing En (Figure 2d,h); double staining with
the anti-Wg antibody showed that Smo also accumulates
in cells expressing Wg (Figure 2g).
The accumulation of Smo in and around cells secreting
Hh protein, strongly suggests that the translation and/or
stability of Smo is promoted by Hh activity. To test this
possibility, we analysed Smo distribution in embryos in
which Hh is ectopically expressed under the control of the
Kr promoter [20]. Such embryos displayed a ubiquitous
expression of Smo between parasegments 5 and 9, pre-
cisely the region in which ectopic Hh expression is driven
by the Kr–Gal4 driver (Figure 2f). As Hh acts by inhibiting
Ptc activity, the effects of Hh on Smo would be expected
to be mediated by Ptc. In embryos homozygous for a ptc
loss-of-function mutation, the modulated pattern of stain-
ing typical of the wild type was lost, indicating that Smo
protein accumulates uniformly in the absence of Ptc
activity (Figure 2e). 
The simplest interpretation of these data is that Ptc func-
tions to block the translation or promote the degradation
of Smo. And, as the spatial distribution of Smo was un-
altered in h–Gal4;UAS–smo transgenic embryos, it would
follow that Ptc activity can suppress accumulation of Smo
protein independently of the levels at which the gene is
transcribed. This effect of Hh/Ptc-mediated signalling on
Smo accumulation provides a simple explanation for the
lack of an effect of ectopic smo expression, namely that the
exogenous protein never accumulates outside the normal
domain of Smo activity.
Surprisingly, however, when h–Gal4;UAS–smo embryos
were probed with the anti-FLAG antibody, a strikingly dif-
ferent pattern of exogenous protein accumulation was
observed (Figure 3a,b). In contrast to the narrow stripes
detected by the anti-SmoC antibody, staining was seen
throughout each h–Gal4 expression domain. This indicates
that the smo mRNA is translated in all cells in which it is
transcribed. It follows that the Ptc-dependent staining
pattern revealed by the anti-SmoC antibody reflects a post-
translational modification of the Smo protein. One possibil-
ity is that Ptc could promote the cleavage of Smo, yielding
a relatively stable but functionally inert truncated form of
the protein in cells not exposed to Hh. In this connection,
it is interesting to note that the SREPB cleavage activating
protein (SCAP), with which Ptc shares some homology,
acts to promote the cleavage of SREBP [21] by chaperon-
ing the latter from the endoplasmic reticulum to the Golgi
[22,23]. Alternatively, however, it could be that Ptc induces
a modification of the Smo protein that masks the epitope
recognised by the anti-SmoC antibody; binding of Hh to
Ptc would suppress this modification, activating the
protein and making it accessible to the antibody. To dis-
criminate between these two possibilities, we generated a
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Figure 3
(a) Late stage 10 h–Gal4;UAS–Flag–smo
embryo stained with anti-FLAG M2 antibody.
The transgenic protein was detected in
alternate segments throughout each hairy
expression domain. (b) This contrasted with the
distribution detected in genotypically identical
embryos using the rabbit anti-SmoC antibody.
Note, in particular, the single broad stripe of
staining (asterisk) in the region corresponding
to hairy domain 1 in (a) compared with the two
narrow stripes (asterisks) in the same region in
(b). (c) Stage 10 h–Gal4;UAS–smo–3HA
embryo stained with anti-HA antibody. The
stripes of HA-positive cells were broader than
those detected with the anti-SmoC antibody,
though those corresponding to hairy domains
2–4 were frequently weaker and narrower than
the rest, mirroring the lower levels of GAL4
expression in these domains. Note, however,
the continuous broad patch of staining in hairy
domain 1 (asterisk), indicative of the
Hh-independent nature of the expression
pattern. (d) Schematic representation of the
Smo protein showing the location of the FLAG
tag (green), the HA tag (blue) and the region of
the carboxy-terminal tail (red) against which the
rabbit anti-SmoC antibody was raised. The
protein is shown in two hypothetical
conformations, inactive (left) and active (right).
Both of the epitope tags appear equally
accessible in both conformations, but the
epitope(s) recognised by the anti-SmoC
antibody are accessible only in the active form,
which is promoted by Hh signalling.













second tagged form of Smo, in this case inserting a
haemagglutinin (HA) tag at the end of the carboxy-termi-
nal tail (see Figure 3d). When embryos expressing this con-
struct under h–Gal4 control were stained with an anti-HA
antibody, a similar broad distribution of the tagged protein
to that revealed by the anti-FLAG antibody was seen
(Figure 3c). This argues against the cleavage model, but
instead suggests that the carboxy-terminal tail undergoes a
Ptc-dependent modification. As our anti-SmoC antibody
was raised against an unmodified bacterially expressed
protein, it seems most likely that this modification results
in a conformational change that exposes epitopes recog-
nised by the antibody. In this regard, it is notable that a
putative dominant gain-of-function mutation in the human
Smo protein is predicted to change the conformation of the
equivalent region of the carboxy-terminal tail against
which the anti-SmoC antibody is directed [24].
Materials and methods
Generation of epitope tagged Smo transgenes
A full-length smo cDNA was assembled from genomic clones [6]. A
fragment encoding the prolactin signal peptide and FLAG tag was
amplified from thrombin receptor cDNA (a generous gift from Shaun R.
Coughlin, University of California at San Francisco) and used to
replace the endogenous sequence encoding Smo signal peptide. The
smo–HA transgene was generated by cloning the triple HA tag present
in the shuttle plasmid pRD67 [11] into the XhoI site of the smo cDNA.
Generation and purification of anti-Smo antibody
A fragment that encodes a region of the carboxy-terminal tail of Smo
from residues 646 to 881 was amplified from the smo cDNA and ligated
in-frame with NdeI/BamHI-digested pET14b (Novagen). ITPG induction
of bacteria transformed with this plasmid yielded a His-tagged fusion
protein of ~30 kD. Inclusion bodies were purified from induced cultures
following standard protocols [25] and used to immunise rabbits. Anti-
bodies specific for Smo were purified from the serum by immunoaffinity
purification [25] using the bacterially expressed fragment fusion protein
coupled to an NHS-activated Sepharose column (Hi Trap NHS-acti-
vated, Amersham-Pharmacia Biotech). Acidic and basic elutions were
pooled and concentrated using an Amicon concentrator.
Antibody stainings and microscopy
Embryos were fixed and stained using standard protocols. The affinity-
purified anti-Smo antibody was used at 1:50–1:100. Monoclonal anti-
FLAG antibodies M1 and M2 (Sigma) were used at a dilution of 1:200.
Monoclonal anti-En (4D9) and anti-Wg (4D4) were used at 1:100 dilu-
tion. Monoclonal anti-β-galactosidase was used at 1:1000. Specimens
were examined and photographed using a Zeiss Axioplan 2 micro-
scope. Figures were composed using Adobe Photoshop 4.0 software
on Macintosh computers.
Supplementary material
Supplementary material including full methodological details is avail-
able at http://current-biology.com/supmat/supmatin.htm.
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